<DOC>
	<DOCNO>NCT02767947</DOCNO>
	<brief_summary>A Randomized , Multi-Center , Double-Blind , Vehicle-Controlled Study</brief_summary>
	<brief_title>Safety Efficacy Product 33525 Pediatric Subjects With Tinea Corporis</brief_title>
	<detailed_description>A Randomized , Multi-Center , Double-Blind , Vehicle-Controlled Study Evaluating Safety Efficacy Product 33525 Pediatric Subjects Tinea Corporis</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<criteria>Key Subjects ( legal guardian/caregiver ) ability willingness sign write informed consent and/or assent ( age appropriate ) . Subject either gender must least 2 year &lt; 18 year age ( 2 17 year , inclusive ) . Subjects clinical diagnosis tinea corporis characterize clinical evidence tinea infection ( least moderate erythema , mild scaling , moderate pruritus ) Subjects must good general health free disease Investigator 's opinion might interfere study evaluation . Subjects/caregiver must able communicate , able understand study procedure , willing comply study requirement . Key Subjects active atopic contact dermatitis area treat . Subjects severe dermatophytoses , mucocutaneous candidiasis , bacterial skin infection . Female subject pregnant and/or nursing planning pregnancy course trial . Subjects test positive pregnancy start test treatment discontinue test treatment follow safety purpose . Subjects immunocompromised ( due disease , e.g. , HIV medication ) . Subjects recent history current drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>